Skip to main content

Table 1 Overview of all measures and corresponding time points

From: Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol

Domain Target Concept (Measure) T0 T1 Training 1 Training 2–8 T2 T3 T4 T5
Screening measures Inclusion Criteria Interview        
Diagnostic status (MINI)       
Primary outcome measures Attentional Bias (Dot-probe)       
Depressive Symptomatology (IDS-SR)    
Mood response and recovery from speech task (I PANAS-SF & short STAI-S)        
Secondary outcome measures Trait Anxiety (STAI-T)     
Positive and Negative Affect (PANAS)     
Rumination (RRS)     
Resilience (RS)      
Cognitive transfer
-Verbal attentional bias (emotional Stroop task)
-Attentional control (classical Stroop task)
-Mental imagery (PIT, SUIS)
Process measures Attentional Bias (Dot-probe training trials)       
Mood in response to training (VAS)       
Credibility and Expectancy (CEQ)        
Cost-effectiveness Quality of Life (EQ-5D-3 L)    
Costs (TIC-P)       
  1. Note. T0 = Intake; T1 = Baseline; T2 = Post-assessment; T3 = One month follow-up; T4 =Six months follow-up; T5 = 12 months follow-up; Measures at T1, Training 1 and T2 are administered by an experimenter, who is blinded to the training conditions. Training 2–8 and all follow-up measures (T3–T5) are administered via the internet